IPCoRV: Impact of Covid-19 on Rhinovirus Epidemic
Study Details
Study Description
Brief Summary
Rhinovirus (RV) has long been known as the main etiological agent of "common colds" among children and adults. Indeed, RV is involved in more than 50% of upper respiratory tract infections (URTIs), mostly characterized by nasal congestion, rhinorrhea, sore throat and cough. RV can also cause mild to severe lower respiratory tract infections (LRTIs) such as acute bronchiolitis, pneumonia and exacerbations of underlying chronic lung diseases. RV circulates worldwide, especially in temperate climate zones (i.e. many areas of the USA and Europe) and is responsible for annual outbreaks from early fall to the end of spring.
The covid-19 pandemic in 2020 seemed to interfere with the usual seasonal epidemics. For example, the winter Respiratory Syncytial Virus (RSV) epidemic in Lyon, France, was delayed for several months and reduced by half in terms of incidence of hospitalization cases. This can be explained by the widespread deployment of barrier gestures and social distancing measures, known as "non pharmacological interventions" (NPI).
However, the Covid-19 pandemic doesn't seem to have the same reducing impact on Rhinovirus epidemic. A better understanding of viral interactions and factors influencing RV epidemiology as well as the identification of populations at greater risk are required to improve preventive strategies and reduce the burden of Rhinovirus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Pre Covid 19 cohort Infants hospitalized in the Pediatric Department of the " Hôpital Femme Mère Enfant ", Lyon, France with a RT-PCR positive for Rhinovirus from 17th March 2019 to 16th March 2020. |
Other: epidemiology
To review medical records to describe diagnosis and severity of the disease.
Other Names:
Other: epidemiology
To compare pre and per Covid-19 epidemics in terms of numbers of admissions and proportion of severe disease.
Other Names:
|
Per Covid 19 cohort year 1 Infant hospitalized in the Pediatric Department of the " Hôpital Femme Mère Enfant ", Lyon, France with a RT-PCR positive for Rhinovirus from 17th March 2020 to 16th March 2021. The need to recruit patients for an additional per-covid year (from 17th March 2021 to 16th March 2022) will be evaluated after the data from the first 2 years of recruitment are available. |
Other: epidemiology
To review medical records to describe diagnosis and severity of the disease.
Other Names:
Other: epidemiology
To compare pre and per Covid-19 epidemics in terms of numbers of admissions and proportion of severe disease.
Other Names:
|
Per Covid 19 cohort, year 2 Infants hospitalized in the Pediatric Department of the " Hôpital Femme Mère Enfant ", Lyon, France with a RT-PCR positive for Rhinovirus from 17th March 2021 to 16th March 2022. The need to recruit patients for this additional cohort will be evaluated after the data from the first 2 years of recruitment are available and analyzed. |
Other: epidemiology
To review medical records to describe diagnosis and severity of the disease.
Other Names:
Other: epidemiology
To compare pre and per Covid-19 epidemics in terms of numbers of admissions and proportion of severe disease.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Evolution of the number of children hospitalized for a Rhinovirus-infection in the period of pre Covid-19 pandemic. [From one year before the SARS-CoV-2 pandemic until the beginning of the SARS-CoV-2 pandemic]
Description of number of clinical picture cases for pre-SARS-CoV-2 pandemic year.
- Evolution of the number of children hospitalized for a Rhinovirus-infection in the period of per-Covid-19 pandemic. [From the beginning of the SARS-CoV-2 pandemic until one year latter]
Description of number of clinical picture cases for per-SARS-CoV-2 pandemic year.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
- Child hospitalized at the " Hopital Femme Mere Enfant ", Lyon, France
-
Positive rhinovirus-PCR
Exclusion Criteria:
-
- parent's refusal to participate
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Hospices Civils de Lyon
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 502_2